Skip to main content
Sign in
Sign up
Sign in
Sign up
About
Issues
Editorial Info
Editorial Board
Permissions
Editorial Board Policies
Contributors
Awards and Recognition
Author Guidelines
Poster Presenters Help
Submit a Manuscript
Peer Reviewer Guidelines
Contact
Feedback and Support
Advertising
AAPP
About Psychiatric Pharmacists
About AAPP
AAPP Annual Meeting
Online ACPE Courses
Join AAPP
About
Issues
Editorial Info
Editorial Board
Permissions
Editorial Board Policies
Contributors
Awards and Recognition
Author Guidelines
Poster Presenters Help
Submit a Manuscript
Peer Reviewer Guidelines
Contact
Feedback and Support
Advertising
AAPP
About Psychiatric Pharmacists
About AAPP
AAPP Annual Meeting
Online ACPE Courses
Join AAPP
Issue Info
Issues
Volume 9: Issue 2
Publication Date:
01 Mar 2019
Online ISSN:
2168-9709
Issues
Volume 9: Issue 2
Publication Date:
01 Mar 2019
Online ISSN:
2168-9709
Select Issue
CLINICAL PEARL
Psychiatric pharmacist's role in overcoming barriers to clozapine use and improving management
Deanna L. Kelly
PharmD, BCPP
and
Raymond C. Love
PharmD, BCPP, FASHP
DOI:
10.9740/mhc.2019.03.064
Abstract
Download PDF
ORIGINAL RESEARCH
Comparison of clozapine monitoring and adverse event management in a psychiatrist-only and a clinical pharmacist-psychiatrist collaborative clinic
Samantha Maryan
PharmD
,
Michelle Harms
PharmD, BCPP
,
Erin McAllister
PharmD, BCPP
, and
Beth DeJongh
PharmD, BCPS, BCPP
DOI:
10.9740/mhc.2019.03.070
Abstract
Download PDF
Evaluation of dextromethorphan with select antidepressant therapy for the treatment of depression in the acute care psychiatric setting
Jill L. Nofziger
PharmD, BCPS
,
Chris Paxos
PharmD, BCPP, BCPS, BCGP
,
Jessica Emshoff
PharmD, BCPS, BCGP
, and
Chanda Mullen
PhD
DOI:
10.9740/mhc.2019.03.076
Abstract
Download PDF
Implementation of a QTc-interval monitoring protocol by pharmacists to decrease cardiac risk in at-risk patients in an acute care inpatient psychiatric facility
Nicole M. Daniel
PharmD
,
Kim Walsh
RPh
,
Henry Leach
PharmD
, and
Lauren Stummer
PharmD
DOI:
10.9740/mhc.2019.03.082
Abstract
Download PDF
Rates of new antipsychotic prescriptions and continuation at discharge from a medical unit in a community teaching hospital serving rural counties
Stephanie V. Phan
PharmD, BCPP
,
Yelena Lugin
PharmD
, and
Katie Morgan
PharmD
DOI:
10.9740/mhc.2019.03.088
Abstract
Download PDF
LITERATURE REVIEW
Review of the many faces of synthetic cannabinoid toxicities
Azita Alipour
PharmD, BCPP, BCGP
,
Puja Baldev Patel
PharmD
,
Zaheera Shabbir
, and
Stephen Gabrielson
MSLIS, AHIP
DOI:
10.9740/mhc.2019.03.093
Abstract
Download PDF
CASE REPORT
Perampanel-induced, new-onset food aversion in a 29-year-old female with medically refractory frontal lobe epilepsy
Marketa Marvanova
PharmD, PhD, BCGP, BCPP
DOI:
10.9740/mhc.2019.03.100
Abstract
Download PDF
INNOVATIVE PRACTICE
Evaluation and optimization of take-home naloxone in an academic medical center
Jordan Cooler
PharmD
,
Clint A. Ross
PharmD, BCPP
,
Sophie Robert
PharmD, BCPP
,
Lauren Linder
PharmD, BCPS, BCPP
,
Ann Marie Ruhe
PharmD, BCPP
, and
Achsah Philip
PharmD, MS, BCPS
DOI:
10.9740/mhc.2019.03.105
Abstract
Download PDF
Get Email Alerts
Get eTOC Alerts
Get Ahead of Print Alerts
Management of antidepressant-induced bruxism
Hayley Cliatt
PharmD
,
Andrew M. Williams
PharmD, BCPP
, and
Jessa Koch
PharmD, BCPP
Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults
Kayla Garvey
PharmD
,
Kobi Griffith
PharmD
,
Emily Carter
MD
,
Wendy Craig
PhD
,
David J. Gagnon
PharmD
,
Richard Riker
MD
, and
Nicolette Centanni
PharmD
Evaluation of burnout among Board-Certified Psychiatric Pharmacists in the United States
Samantha Catanzano
PharmD, BCPP
,
Jennifer N. Gemmellaro
PharmD, BCPP, BCPS
,
Melissa Mooers Gross
BS, PharmD, MHA, BCPP, BCPS, BCGP, BCIDP, CPEL, CPPS
,
Monica Fahmy
PharmD, BCPP, BCPS
,
Gregory H. Payne
MBA, CAE
, and
Kelly C. Lee
PharmD, MAS, BCPP, FCCP
Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report
Kristin Waters
PharmD, BCPS, BCPP
,
Victoria Popielarz
BS, PharmD Candidate
,
Joseph Lumasag
BS, PharmD Candidate
,
Sara Wiesenfeld
BS, PharmD Candidate
, and
Ashley Tewksbury
PharmD, BCPP
Clozapine plasma level toxicity induced by a pharmacokinetic interaction with bupropion: A case report
Kelly N. Gable
PharmD, BCPP
and
Jaron Asher
MD
About
Issues
Advertising
Permissions
Facebook
X
LinkedIn
eISSN
: 2168-9709
Powered by
PubFactory